Paul O. Sheppard
Bristol-Myers Squibb
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Paul O. Sheppard.
Analytical Chemistry | 2017
Jing Li; Hui Wei; Stanley R. Krystek; Derek Bond; Ty Brender; Daniel Cohen; Jena Feiner; Nels Hamacher; Johanna Harshman; Richard Y.-C. Huang; Susan H. Julien; Zheng Lin; Kristina Moore; Luciano Mueller; Claire Noriega; Preeti Sejwal; Paul O. Sheppard; Brenda L. Stevens; Guodong Chen; Adrienne A. Tymiak; Michael L. Gross; Lumelle A. Schneeweis
Epitope mapping the specific residues of an antibody/antigen interaction can be used to support mechanistic interpretation, antibody optimization, and epitope novelty assessment. Thus, there is a strong need for mapping methods, particularly integrative ones. Here, we report the identification of an energetic epitope by determining the interfacial hot-spot that dominates the binding affinity for an anti-interleukin-23 (anti-IL-23) antibody by using the complementary approaches of hydrogen/deuterium exchange mass spectrometry (HDX-MS), fast photochemical oxidation of proteins (FPOP), alanine shave mutagenesis, and binding analytics. Five peptide regions on IL-23 with reduced backbone amide solvent accessibility upon antibody binding were identified by HDX-MS, and five different peptides over the same three regions were identified by FPOP. In addition, FPOP analysis at the residue level reveals potentially key interacting residues. Mutants with 3-5 residues changed to alanine have no measurable differences from wild-type IL-23 except for binding of and signaling blockade by the 7B7 anti-IL-23 antibody. The M5 IL-23 mutant differs from wild-type by five alanine substitutions and represents the dominant energetic epitope of 7B7. M5 shows a dramatic decrease in binding to BMS-986010 (which contains the 7B7 Fab, where Fab is fragment antigen-binding region of an antibody), yet it maintains functional activity, binding to p40 and p19 specific reagents, and maintains biophysical properties similar to wild-type IL-23 (monomeric state, thermal stability, and secondary structural features).
Archive | 2006
Lowell J. Brady; Kevin M. Klucher; Chung-leung Chan; Dennis L. Dong; Hong Y. Liu; Paul O. Sheppard; Thomas R. Bukowski
Archive | 2009
Margaret D. Moore; Michael G. Dodds; Paul O. Sheppard; Henrik Andersen
Archive | 2013
Brenda L. Stevens; Alison Witte; Mark W. Rixon; Josephine M. Cardarelli; Thomas D. Kempe; Scott R. Presnell; Mohan Srinivasan; Susan C. Wong; Guodong Chen; Hui Wei; Stanley R. Krystek; Lumelle A. Schneeweis; Paul O. Sheppard; Indrani Chakraborty; Mian Gao; Steven Sheriff; Noah Ditto; Nels B. Hamacher; Thomas E. Edwards; Kateri Atkins; Tracy Arakaki
Archive | 2011
Paul O. Sheppard; Henrik Andersen
Archive | 2016
Mark Maurer; Tseng-Hui Timothy Chen; Brigitte Devaux; Mohan Srinivasan; Susan H. Julien; Paul O. Sheppard; Daniel F. Ardourel; Indrani Chakraborty
Archive | 2013
Brenda L. Stevens; Alison Witte; Mark W. Rixon; Josephine M. Cardarelli; Thomas D. Kempe; Scott R. Presnell; Mohan Srinivasan; Susan C. Wong; Guodong Chen; Hui Wei; Stanley R. Krystek; Lumelle A. Schneeweis; Paul O. Sheppard; Indrani Chakraborty
Archive | 2018
Xiao Min Schebye; Mark J. Selby; Michelle Minhua Han; Christine Bee; Andy X. Deng; Anan Chuntharapai; Brigitte Devaux; Huiming Li; Paul O. Sheppard; Alan J. Korman; Daniel F. Ardourel; Ekaterina G. Deyanova; Richard Y.-C. Huang; Guodong Chen; Michelle Kuhne; Hong-An Troung
Archive | 2016
Paul O. Sheppard; Henrik Andersen; Xiang Shao; Chetana Rao-Naik; Arvind Rajpal
Archive | 2014
Brenda L. Stevens; Alison Witte; Mark W. Rixon; Josephine M. Cardarelli; Thomas D. Kempe; Scott R. Presnell; Mohan Srinivasan; Susan C. Wong; Guodong Chen; Hui Wei; Stanley R. Krystek; Lumelle A. Schneeweis; Paul O. Sheppard; Indrani Chakraborty